A previous study identified heterozygous missense KEAP1 mutations in 5 of 27 (19%) ovarian carcinomas, although frequencies differ across subtypes (29% and 8% in clear cell and serous tumors, resp. Here, KEAP1 is linked to ovarian carcinoma.